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ABSTRACT
The immune system undergoes rapid reconstitution after autologous or syngeneic bone marrow transplanta-
tion with the re-establishment of tolerance to self-antigens. Administration of drugs such as cyclosporine that
inhibit thymic-dependent clonal deletion disrupts the reconstitution of the immune system. In the absence of
a peripheral regulatory T cells eliminated by the preparative regimen, systemic autoimmunity with pathology
similar to graft-versus-host disease often develops. Moreover, the resolution of autoaggression is dependent
on the reconstitution of CD4 regulatory T cells. This study examined the specificity and function of this
regulatory population assessed ex vivo that plays a critical role in down-regulating the autoreactive T lym-
phocyte response in cyclosporine-induced syngeneic graft-versus-host disease. The results suggest that both
the antigen-specific regulatory and pathogenic effector T cells recognize a common peptide antigen framework
(CLIP, a peptide derived from the invariant chain) presented by major histocompatibility complex class II
molecules. Analysis of the CD4 T-cell compartment revealed two subsets of CLIP-reactive T cells that
differentially require the N- and C-terminal flanking domain of this peptide. Regulatory function is associated
with the cells that require the C-terminal flanking domain. This population expresses the Foxp3 nuclear
transcription factor and plays a critical role in re-establishing tolerance to self-major histocompatibility
complex class II antigens. In addition to suppressing the production of type 1 cytokines, these regulatory
T cells can direct the apoptotic death of the pathogenic autoreactive lymphocytes. This study also suggests that
the development of functional regulatory activity is an active response initiated by the presence of autoreactive
lymphocytes that can present the target antigen (major histocompatibility complex class II CLIP) to the
regulatory T cells. Moreover, this process can be mimicked by peptide antigen in the absence of the pathogenic
effector lymphocytes leading to the development of functional regulatory T-cell activity.
© 2006 American Society for Blood and Marrow Transplantation
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oNTRODUCTION
Reconstitution of the immune system occurs quite
apidly after syngeneic or autologous bone marrow
ransplantation (BMT). In addition to the generation
f a competent T-cell repertoire, immunologic toler-
nce to self-major histocompatibility complex (MHC)
ntigens is re-established. Disrupting thymic-depen-
ent negative selection during immune reconstitution,
owever, can lead to the development of an MHC
lass II-dependent autoimmune syndrome with pa-
hology remarkably similar to graft-versus-host dis- i
18ase (GVHD) [1-7]. Interestingly, administration of
mmunosuppressive drugs such as cyclosporine (CsA)
hat directly impair thymic-dependent clonal deletion
an also elicit a systemic autoaggression syndrome.
ermed “syngeneic GVHD,” this autoimmune syn-
rome is primarily mediated by a highly restricted rep-
rtoire of autoreactive T cells that recognize the MHC
lass II invariant chain peptide (CLIP) complex [1-5].
The failure to delete autoreactive T cells because
f the impairment of negative selection, by itself, is
nsufﬁcient to allow for the development of syngeneic
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Immune Tolerance to MHC Class Antigens
BVHD. A peripheral immunoregulatory compart-
ent must be inactivated or eliminated by the BMT
reparative regimen to provide a permissive environ-
ent for the autoreactive cells to manifest autoimmu-
ity [8-11]. Mature T cells in the periphery can pre-
ent both the induction and the adoptive transfer of
his autoaggression syndrome [8-11]. In naïve animals,
ffective suppression of syngeneic GVHD required
oth CD4 and CD8T cells. Interestingly, the pres-
nce of autoreactive T cells induces dynamic changes
n the regulatory compartment including the activa-
ion of CD4 T cells that are capable of suppressing
he adoptive transfer of syngeneic GVHD [9-11]. Al-
hough antigen-speciﬁc CD8 T cells may have reg-
latory potential, the dominance of CD4T cells may
rise from their selection on and response to MHC class
I antigens. Furthermore, CD4 regulatory T cells may
lso beneﬁt from cytokines produced by mature T cells
ecognizing cognate antigen (CLIP). In addition, the
esolution of syngeneic GVHD and re-establishment
f active dominant tolerance are critically dependent
n the reconstitution of this regulatory subset after
essation of CsA treatment [11,12].
This study examines the speciﬁcity and function of
LIP-reactive T-cell subsets within the CD4 T-cell
ompartment. Changes in the functional behavior
ithin antigen-speciﬁc subpopulations over time ap-
ear to play a critical role in down-regulating the
utoreactive T-cell response in syngeneic GVHD.
he results also suggest that both the antigen-speciﬁc
egulatory and pathogenic effector T cells recognize a
ommon peptide antigen framework presented by
HC class II molecules. The regulatory T cells ex-
ress the Foxp3 nuclear transcription factor and play a
ritical role in re-establishing tolerance to self-MHC
lass II antigens. In addition to suppressing the pro-
uction of type 1 cytokines, some CLIP-reactive reg-
latory T cells can direct the apoptotic death of the
athogenic autoreactive lymphocytes. This study also
uggests that an active response to the autoreactive
ymphocytes promotes the development of functional
egulatory T-cell activity. Moreover, this process can
e mimicked by peptide antigen in the absence of the
athogenic effector lymphocytes leading to functional
egulatory T-cell activity.
ETHODS
nduction of Syngeneic GVHD
Syngeneic GVHD was induced in female Lewis
ats 4 to 6 weeks of age (Charles River Breeding
aboratories, Wilmington, Mass) using the standard
rotocol as previously described [1-5]. After total-
ody irradiation (9.5 Gy) and reconstitution with syn-
eneic marrow, recipient animals were treated daily
ith 10 mg/kg CsA (dissolved in 0.02% ethanol and t
B&MT% emulphor in water) administered subcutaneously
or 30 days. The onset of syngeneic GVHD occurred
ithin 7 to 14 days after discontinuation of CsA treat-
ent or the adoptive transfer of effector T cells as
videnced by the development of erythema, rufﬂed
ur, and progressive weight loss. Syngeneic GVHD
as conﬁrmed by histologic analysis of target tissues
1,5,10].
solation of Effector and Regulatory T Cells
Spleens were harvested within 7 to 10 days after
he initial onset of syngeneic GVHD (effector cells)
nd within 10 to 14 days after resolution of disease
regulatory cells). Splenic T cells were enriched by nylon
ool fractionation. Purity assessed ﬂow cytometric
nalysis revealed that greater than 95% of the cells
xpressed CD3. In addition, splenic T cells enriched
y nylon wool fractionation were harvested form nor-
al animals 2 weeks after an intravenous challenge
ith 60  106 irradiated (2000R) effector T cells
arvested from animals with early onset (day 7-10)
yngeneic GVHD [8-10]. Previous studies reveal that
riming naïve animals with the syngeneic GVHD effec-
or lymphocytes activates the regulatory population with
he acquisition of in vitro regulatory function resistant to
adiation whereas challenge with irradiated T cells from
ormal animals had no effect [10].
Normal Lewis rats were also immunized intrader-
ally with antigen-presenting cells (APCs) (isolated
y plastic differential adherence; 5  104 cells/site at
sites) pulsed with truncated variants of CLIP (see
elow) as previously described [13,14]. Splenic T cells
ere harvested 2 weeks after intradermal immuniza-
ion with the peptide-loaded APCs. The spleens were
ushed through a wire mesh screen to obtain a single
ell suspension and the mononuclear cells isolated by
col-hypaque density centrifugation [5,10]. The cells
ere further fractionated depleting speciﬁc subsets based
n expression of the CD4, CD8, and CD25 cell surface
arkers with immunomagnetic beads as previously de-
cribed [5,8,10]. Depletion rather than positive selec-
ion was used in the in vivo adoptive transfer studies to
void the potential confounding effects of antibody to
hese markers on the cell surface because previous
tudies indicate that antibody to these markers on the
ell surface inhibits their in vivo regulatory function
10]. Efﬁciency of depletion was conﬁrmed ﬂow cyto-
etrically. On average, more than 95% of the cells
xpressing a speciﬁc cell surface determinant were
emoved from the splenic T-cell population after de-
letion.
doptive Transfer
Lethally irradiated (9.5 Gy) recipients were grafted
ith syngeneic bone marrow (40  106) together with
he intravenous infusion of syngeneic GVHD effector
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5ymphocytes (30  106) and graded numbers (10,15,
0 106) of regulatory T cells as previously described
10]. An ex vivo/in vitro model was used to evaluate
he speciﬁcity of the regulatory population as previ-
usly described [10]. The effector and regulatory
cells (irradiated 1250R) were incubated in vitro for
8 hours prior. Before this coculture period, the reg-
latory and effector T cells were pretreated with ei-
her antibodies to FasL (CD95 Ligand, Pharmingen,
an Diego, Calif), MHC class I, MHC class II
Pharmingen), or CLIP [5] at concentrations of 1
g/mL for 1 hour at 4°C and washed 3 times in RPMI
640 before coculture. Controls included effector and
egulatory cells pretreated with normal IgG. After the
ncubation period, the cells were extensively washed
nd adoptively transferred into the secondary recipi-
nts. The animals were examined daily (for 6 weeks)
nd assessed for the development of syngeneic GVHD
s described above.
solation of MHC Class II CLIP-Specific T Cells
A soluble rat (Lewis) MHC class II mouse immu-
oglobulin fusion product (sMHC class II-Ig) loaded
ith peptide was used to isolate antigen-speciﬁc effec-
or T cells as previously described [5,14]. The sMHC
lass II-Ig fusion product, puriﬁed by size exclusion on
Sephacryl 16/60 G-200 column (Pharmacia, Piscat-
way, NJ) was labeled with the ﬂuorochrome Alexaf-
our 488 or 546 (Molecular Probes, Eugene, Ore) or
iotinylated (counter staining with cychrome strepta-
idin) as previously described [5,14]. Brieﬂy, splenic
cells (1-5  106) were stained with conjugated
MHC class II-Ig (1 hour, 4°C) and washed 3 times in
PMI 1640. The cells were sorted on a Becton-Dick-
nson FACSVantage (San Jose, CA). Multicolor ﬂow
ytometry was used to isolate subsets of antigen-spe-
iﬁc T cells based on expression of the CD4, CD8,
nd CD25 cell surface markers (phycoerythrin [PE]-
r ﬂuorescein isothiocyanate [FITC]-conjugated
ouse antirat CD8, anti-CD4, and CD25 monoclonal
ntibodies, Serotec, Harlan Bioproducts for Science,
ndianapolis, Ind). Speciﬁcity of the isolated T-cell
ubsets was conﬁrmed as previously described with the
LIP-reactive T lymphocytes unable to kill target
ells loaded with unrelated peptides (c-neu peptide,
llopeptide, CLIP-inverted ﬂanking domains) [5,14].
n addition, cells sorted based on reactivity to control
eptides (ie, c-neu) did not recognize CLIP-loaded
arget cells.
LIP Peptides and Loading
Truncated variants of rat CLIP containing just the
HC class II binding region or this region with either
he N- or C-terminal ﬂanking domains (sequences:
-terminal, MRMATPLLMRPLSMD, designated
LIP-C; N-terminal, KPVSPMRMATPLLMR, des- l
20gnated N-CLIP; MHC class II binding domain, des-
gnated BD-CLIP; MRMATPLLMR) were chemi-
ally synthesized and puriﬁed by high-pressure liquid
hromatography (Quality Controlled Biochemicals,
opkinton, Mass) [4,5,13,14]. Control peptides in-
luded MHC class II binding peptides from the c-neu
ncogene, an allopeptide (from Brown Norway strain
ats) or a CLIP variant with the ﬂanking domains
nverted as previously reported [4,5,13,14]. The pep-
ides (92% purity) were diluted to 10 mol/L in
PMI 1640 before loading the soluble MHC class
I-Ig construct. The sMHC class II-Ig construct was
oaded in molar excess incubating 1 g of the con-
truct in 10 mol/L of the peptides for 2 hours at 4°C.
nbound peptide was removed by size exclusion chro-
atography.
uantitative Reverse Transcriptase Polymerase
hain Reaction
Quantitative reverse transcriptase polymerase chain
eaction (PCR) (Taqman, Applied Biosystems, ABI,
oster City, Calif) was used to assess levels of cytokine
nd cell surface accessory molecule messenger RNA
mRNA) as previously described [4,14]. RNA was ex-
racted and puriﬁed from the lysate of 1 to 5  105
ells with 500 L Trizol (Invitrogen, Carlsbad, Calif)
eagent [4,14] and complementary DNA prepared
ith Ready-to-Go You Prime First Strand (Pharma-
ia). The primers and probes for the cytokine genes
IL-2, IL-4, IFN, IL-10, and Foxp3) are commer-
ially available from ABI [4,5,13,14]. Samples were
nalyzed by multiplexed real-time quantitative PCR
4,14]. Data were analyzed with software (Sequencer
etection, Version 1.6 ABI) with the results normal-
zed against mRNA transcripts for the housekeeping
ene glyceraldehyde-3-phosphate dehydrogenase
4,14]. For statistical comparison (t test), the fold in-
rease or decrease in mRNA transcript levels of a
elect population relative to another population was
alculated.
n Vitro Culture
Regulatory and effector T cells were suspended in
omplete tissue culture medium consisting of RPMI
640 supplemented with glutamine and 5% heat-in-
ctivated normal rat serum or fetal calf serum as pre-
iously described [3-5]. The cells (1  105) were
ultured separately or in combination in ﬂat bottom
icrotiter wells at 37°C and stimulated with peptide-
oaded syngeneic APCs (1  104). After 48 hours of
ncubation, the cells were harvested and assessed for
RNA transcripts by quantitative PCR.
ESULTS
Initial studies assessed the phenotype of the regu-
atory T cells after an intravenous challenge (priming)
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Immune Tolerance to MHC Class Antigens
Bf naïve animals with irradiated (2000R) syngeneic
VHD effector T lymphocytes (60  106). Regula-
ory function was assessed 14 days after priming.
raded numbers of splenic T cells (10, 15, 30  106)
rom the animals primed with the autoreactive lym-
hocytes were adoptively transferred with 30  106
ffector spleen cells (harvested from animals 7-10 days
fter the initial development of syngeneic GVHD)
nto secondary, bone marrow–reconstituted syngeneic
ats. As demonstrated in Figure 1A, unfractionated
rimed regulatory T cells effectively suppressed the
doptive transfer of syngeneic GVHD. Depletion of
ells expressing either the CD4 or CD25 cell surface
arkers eliminated the ability to suppress the adoptive
ransfer of syngeneic GHVD. On the other hand,
epletion of CD8 T cells failed to remove the reg-
latory activity. The results indicate that cells capable
f regulating the activity of the syngeneic GVHD
utoreactive lymphocytes reside within the CD4
-cell subset after priming with the autoreactive lym-
hocytes. Similar results were obtained evaluating
egulatory T-cell activity in the spleens of animals
arvested within 10 to 14 days after resolution of
yngeneic GVHD (Figure 1B). Previous studies indi-
ate that CD4T cells from naïve (unprimed) animals
o not suppress the adoptive transfer of syngeneic
VHD unless accompanied by CD8 T lymphocytes
nd only at high (2) regulatory:effector cell ratios
8,10]. These data suggest that active recognition of
he autoreactive lymphocytes or experimental chal-
enge with the effector cells appears to be a necessary
equirement to induce functional regulatory activity.
Regulatory T-cell function was also assessed in
itro. Primed regulatory T cells (1  105, irradiated
2.5 Gy) were cocultured with an equal number of
yngeneic GVHD effector lymphocytes and stimu-
ated with 1 104 syngeneic APCs loaded with CLIP.
igure 1. Suppression of adoptive transfer of syngeneic GVHD. S
VHD or from normal animals after intravenous challenge with 6
D8, or CD25 cells with immunomagnetic beads. Graded numbe
n  6-8) along with 30  106 effector T cells harvested from anim
ere examined daily for 6 weeks for development of syngeneic GVfter 48 hours of culture, the cells were harvested and v
B&MTssessed for cytokine transcripts by quantitative PCR.
roduction of IFN and IL-2 mRNA transcripts was
igniﬁcantly (P  .01) reduced (20-fold) when the
egulatory T cells were cocultured with the autoreac-
ive lymphocytes compared with cultures that did not
eceive the regulatory population (Figure 2). The fold
eduction of mRNA transcripts in the presence of the
egulatory T cells in 3 separate experiments averaged
5.6  3.8 (SD). Depletion of CD4 T cells or cells
xpressing the CD25 cell surface marker eliminated
he regulatory T-cell activity. Identical results were
btained in two additional experiments demonstrating
hat depleting either CD4 or CD25 T cells elimi-
ated regulatory function. Comparatively, addition of
ormal spleen cells did not signiﬁcantly inhibit the in
itro cytokine response of the autoreactive lympho-
ytes (see below).
The speciﬁcity of the regulatory T cells was eval-
ated using an ex vivo/in vivo adoptive transfer model.
his model is based on the ﬁndings that the in vitro
ctivity of the primed regulatory T cells is radio re-
istant [10]. Irradiated regulatory lymphocytes can in-
ctivate the effector T cells in vitro, although they
annot suppress the adoptive transfer of syngeneic
VHD when transferred separately. Primed regula-
ory cells (30  106; irradiated 1250R) were cocul-
ured for 18 hours with an equal number of syngeneic
VHD effector lymphocytes before adoptive transfer
nto secondary recipients. As summarized in Table 1,
ffector T cells cocultured with the primed regulatory
ells failed to adoptively transfer syngeneic GVHD.
reatment of the effector lymphocytes with antibod-
es to either MHC class II or to CLIP before coculture
revented their inactivation by the regulatory cells
llowing the transfer of syngeneic GVHD into the
econdary recipients. On the other hand, anti-MHC
lass I antibody treatment did not prevent the inacti-
T cells were harvested from animals after resolution of syngeneic
06 effector T cells. Regulatory population was depleted of CD4,
gulatory cells were adoptively transferred into secondary recipients
acute syngeneic GVHD (7-10 days after initial onset). Recipients
resence or absence of syngeneic GVHD was conﬁrmed by biopsy.plenic
0  1
rs of re
als withation of the effector cells. Treatment of the regula-
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A. D. Hess and C. J. Thoburn
5ory T cells with any of these antibodies did not
nhibit their functional activity. Taken together, the
esults indicate that the regulatory T cells recognize
he MHC class II CLIP complex expressed by the
yngeneic GVHD effector lymphocytes. Moreover,
he results of the depletion studies place these anti-
en-speciﬁc regulatory T cells within the CD4 and
ot the CD8 compartment. The depletion of regula-
ory activity by antibody to CD25 suggests that either
hese cells were recently activated in vivo or alterna-
ively belong to the population that bears CD4 and
D25 on emerging from the thymus. Similarly, the
ossibility that effective regulation in vivo requires the
ynergistic activity of a CD4	CD8	CD25 subset
annot be excluded.
Previous studies evaluating the speciﬁcity of the
utoreactive T cells in syngeneic GVHD revealed two
unctionally distinct subsets of CLIP-reactive T cells
igure 2. Suppression of in vitro cytokine response of autoreactive e
fter intravenous challenge with 60  106 effector T cells. Regu
mmunomagnetic beads. Regulatory T cells (1  105) were irrad
arvested from animals with syngeneic GVHD. Cells were stimula
ncubation, cells were harvested and assessed for levels of IL-2 an
ranscripts were not detected in control cultures of irradiated regu
gainst mRNA transcript levels for housekeeping gene, GAPDH.
able 1. Speciﬁcity of Primed Regulatory T Cells
Coculture Before Adoptive T
Effector Population
yngeneic GVHD effector T cells N
yngeneic GVHD effector T cells U
yngeneic GVHD effector T cells P
yngeneic GVHD effector T cells  anti-MHC class I P
yngeneic GVHD effector T cells P
yngeneic GVHD effector T cells  anti-MHC class II P
yngeneic GVHD effector T cells P
yngeneic GVHD effector T cells  anti-CLIP P
yngeneic GVHD effector T cells P
yngeneic GVHD effector T cells (30  106) were cocultured wit
1250R) for 18 hours at 37°C before adoptive transfer into secon
and regulatory cells were separately treated with antibodies (1g/
of the effector and regulatory T cells with normal IgG did not
excess antibody. Irradiated regulatory T cells are active in vitro
syngeneic GVHD.
22hat have divergent cytokine proﬁles [4]. These two
ubpopulations can be separated based on their prefer-
ntial requirement for the N- or C-terminal ﬂanking
omain of CLIP (designated N-CLIP and CLIP-C,
espectively). Because anti-CLIP antibody could block
he regulatory activity, it was important to determine
hether N-CLIP- and CLIP-C-reactive lymphocytes
ad regulatory activity. A soluble MHC class II-Ig
onstruct (loaded with truncated peptide variants of
LIP) was used to identify and isolate the subsets of
LIP-reactive T cells’ ﬂow cytometrically. In vitro
tudies were undertaken to evaluate the CD4CD25
-cell subpopulation (a subpopulation that includes
egulatory T cells) for N-CLIP- and CLIP-C-reactive
cells as previously described [4]. Analysis of spleen
ells from normal animals revealed that approximately
% of the total lymphocyte population consisted of
D4 CD25 T cells (Table 2). Although both sub-
cells to CLIP. Splenic T cells were harvested from normal animals
population was depleted of CD4, CD8, or CD25 cells with
250R) and incubated with equal number of autoreactive T cells
h syngeneic APCs (1  104) loaded with CLIP. After 48 hours of
mRNA transcripts by quantitative PCR. IFN and IL-2 mRNA
cells cultured with peptide-loaded APCs. Data were standardized
Incidence of
Syngeneic GVHDRegulatory Population
6/6
ed regulatory cells (naïve) 6/6
regulatory cells 0/6
regulatory cells 0/6
regulatory cells  anti-MHC class I 0/6
regulatory cells 6/6
regulatory cells  anti-MHC class II 0/6
regulatory cells 6/6
regulatory cells  anti-CLIP 0/6
ual number of primed CD4 regulatory lymphocytes (irradiated–
ne marrow reconstituted recipients. Before coculture, the effector
MHC class I, MHC class II, or CLIP for 1 hour at 4°C. Treatment
their functional activity. The cells were washed 3 times to remove
hen transferred separately fail to suppress the adoptive transfer offfector
latory
iated (1
ted wit
d IFN
latoryransfer
one
nprim
rimed
rimed
rimed
rimed
rimed
rimed
rimed
h an eq
dary bo
mL) to
inhibit
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Immune Tolerance to MHC Class Antigens
Bets were detected within this compartment, the ma-
ority of cells were CLIP-C reactive. In animals with
yngeneic GVHD, the percent of CD4 CD25
cells was modestly increased (approximately 2-fold).
n addition, there were changes in the relative pro-
ortion of the CLIP-reactive T-cell subsets. During
ctive disease, the majority of the cells were N-CLIP
eactive. This increased percentage of CD4 T cells
xpressing CD25 in animals with syngeneic GVHD may
eﬂect the activation of autoreactive effector T cells
ather than the expansion of the regulatory T-cell subset.
nterestingly, the percentages of CD4CD25 T cells
nd the relative proportions of N-CLIP- and CLIP-C-
eactive lymphocytes returned to levels detected in nor-
al animals after disease resolution. Ex vivo assessment
f their functional behavior, however, revealed striking
ifferences between the N-CLIP- and CLIP-C-reactive
D4CD25 T-cell subsets.
The N-CLIP- and CLIP-C-reactive CD4CD25
-cell subsets were assessed ex vivo for levels of type
and 2 cytokine mRNA transcripts by quantitative
CR and a representative experiment (1 of 4) is illus-
rated in Figure 3. Interestingly, IFN mRNA tran-
cript levels were substantially elevated (1000-fold
ncrease on average; P  .001, n  4) in both the
-CLIP- and CLIP-C-reactive CD4CD25 subsets
solated from animals with syngeneic GVHD com-
ared with these two subsets isolated from normal
nimals. High levels of IL-2 mRNA transcripts were
lso detected in these subsets. Comparatively, IL-2
ranscripts were not detected in the CD4CD25
-CLIP-reactive T cells whereas only low levels of
ranscripts for this cytokine were expressed by the
able 2. CLIP-speciﬁc T Cells in the CD4CD25 Lymphocyte
ubset
Subset
Percent CD4CD25
T Cells
Percent Total
Lymphocytes
ormal Lewis rats
CD4CD25 3.9
CLIP-C 3.2 0.12
N-CLIP 0.5 0.02
ctive syngeneic GVHD
CD4CD25 7.9
CLIP-C 1.1 0.09
N-CLIP 6.3 0.49
fter resolution of disease
CD4CD25 4.2
CLIP-C 3.6 0.15
N-CLIP 0.3 0.01
plenic lymphocytes were harvested from normal animals and from
animals with active syngeneic GVHD (day 7 after onset) and
within 10 days after resolution of active disease. CLIP-C	 and
N-CLIP	 reactive T cells in the CD4CD25 subset (deter-
mined ﬂow cytometrically by staining with FITC-anti CD4 and
PE-anti CD25) were identiﬁed by staining with the biotinylated
soluble MHC class II-Ig loaded with the truncated variants of
CLIP and counterstaining with streptavidin-cychrome.D4CD25 CLIP-C-reactive cells isolated from T
B&MTormal animals. On the other hand, elevated levels of
ype 2 cytokine (IL-4, IL-10) mRNA transcripts were
lso detected in the N-CLIP- and CLIP-C-reactive
-cell subsets harvested from animals with active
VHD. Although levels of IL-4 and IL-10 mRNA
ranscript levels were modestly increased (5- to 10-
old) in N-CLIP-reactive T cells harvested from ani-
als with syngeneic GVHD, there was nearly a 100-
old increase in IL-4 mRNA transcripts in the
D4CD25 CLIP-C-reactive T-cell subset. The
p-regulation of type 1 cytokine mRNA transcripts
uring syngeneic GVHD probably reﬂects the activa-
ion of the autoreactive effector lymphocytes because
ntigen stimulation induces CD25 expression in T
ells. On the other hand, the up-regulation of IL-4
RNA transcript expression in the CLIP-C-reactive
ubpopulation may reﬂect the activation of an autore-
ctive T cell that allows for progression of disease
14]. Analysis of the CLIP-reactive CD4CD25
ubsets after resolution of syngeneic GVHD, how-
ver, revealed a marked increase (approximately 100-
o 150-fold) in levels of IL-10 mRNA transcripts
ithin the CLIP-C-reactive subpopulation. Levels of
L-10 mRNA were found to be consistently elevated
mean  SD; 117  9, 163  21) in this population
arvested from animals that recover from syngeneic
VHD compared with the levels detected in this
ubset harvested from normal animals or from animals
ith active disease, respectively. In contrast, levels of
RNA transcripts for IL-2, IL-4, and IFN were
imilar to the levels detected in the CLIP-speciﬁc
ubsets isolated from normal animals.
The N-CLIP- and CLIP-C-reactive CD4CD25
cells were also evaluated for Foxp3 mRNA tran-
cript levels, a nuclear transcription factor commonly
xpressed in regulatory T cells [15,16]. A representa-
ive experiment illustrated in Figure 4 reveals that
oxp3 mRNA transcripts were predominantly expressed
n the CLIP-C-reactive CD4CD25T-cell subset iso-
ated from naïve animals. Levels of Foxp3 mRNA tran-
cript levels were markedly reduced (approximately 20-
old) in CLIP-C-reactive CD4CD25 T cells isolated
rom animals with syngeneic GVHD. In contrast, the
p-regulation of Foxp3 gene expression was concordant
ith the resolution of syngeneic GVHD. Levels of
oxp3 mRNA transcripts were markedly increased in the
LIP-C-reactive CD4CD25 T-cell subset. Levels of
oxp3 mRNA transcripts were found to be consistently
levated in this subset of CLIP-reactive CD4CD25
cells isolated from animals that recover from synge-
eic GVHD compared with levels detected in this subset
f cells isolated from normal animals and animals with
yngeneic GVHD (mean fold increases of 62  8.6 and
04  12.7, respectively; P  .01). Interestingly, Foxp3
ranscript levels in the N-CLIP-reactive CD4CD25-cell subset were much lower (approximately 30-fold)
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5verall with only minimal changes detected over the
ourse of the disease.
Additional studies assessed whether the CLIP-re-
ctive CD4 T-cell subsets had functional regulatory
ctivity. N-CLIP- and CLIP-C-reactive T cells iso-
igure 3. Ex vivo analysis of cytokine mRNA transcripts in CLI
D4CD25 T cells were isolated ﬂow cytometrically from splee
esolution of disease. Cells were assessed for cytokine (IL-2, IL-4
tandardized against mRNA transcript levels for housekeeping gen
igure 4. Foxp3 Expression in CLIP-reactive CD4CD25 T-cell
ubsets. N-CLIP- and CLIP-C-reactive CD4CD25 T cells were
solated ﬂow cytometrically from normal animals, animals with
yngeneic GVHD, and animals after resolution of disease. Foxp3
RNA transcript levels were assessed by quantitative PCR. DataTere standardized against GAPD mRNA transcript levels.
24ated ex vivo from animals after resolution of synge-
eic GVHD were assessed for their ability to suppress
he in vitro response of the autoreactive effector
cells. Production of mRNA transcripts for both
FN and IL-2 in response to stimulation with the
arget antigen (CLIP presented by syngeneic APCs)
as suppressed when CLIP-C-reactive T cells were
ocultured with the syngeneic GVHD effector T cells
Figure 5). Two additional experiments yielded re-
arkably similar results. On average (n  3), there
as more than a 40-fold reduction in the production
f type 1 cytokine mRNA transcripts when the CLIP-
-reactive subset was cocultured with the autoreactive
effector T cells. Depletion of CD4 T cells elimi-
ated the regulatory activity from the CLIP-C-reac-
ive subpopulation. On the other hand, the in vitro
esponse of the autoreactive effector T cells was mar-
inally altered by any of the N-CLIP-reactive T-cell
ubsets. Regulatory activity was primarily contained
ithin the CLIP-C-reactive CD4 T-cell subset.
Previous studies suggest that the development of
unctional regulatory activity in normal animals is
rimarily initiated by a response to the autoreactive
ive CD4CD25 T-cell subsets. N-CLIP- and CLIP-C-reactive
ormal animals, animals with syngeneic GVHD, and animals after
, and IFN) mRNA transcripts by quantitative PCR. Data were
DH. ND  Not detected.P-react
ns of n
, IL-10cells [10]. Studies were undertaken to determine
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Bhether in vivo functional regulatory population could
e activated by experimental challenge with the CLIP-C
eptide and a representative experiment (1 of 3) is illus-
rated in Figure 6. Normal Lewis rats were immunized
ntradermally with APCs (4 sites, 5  104 cells/site)
igure 5. Regulation of in vitro cytokine tesponse by N-CLIP- and
ere isolated ﬂow cytometrically from animals after resolution of sy
f cells expressing CD4, CD8, or CD25 with immunomagnetic bea
o suppress in vitro response of syngeneic GVHD effector lympho
04). After 48 hours of culture, cells were harvested assessed for lev
L-2 mRNA transcripts were not detected in control cultures of irra
gainst mRNA transcript levels for housekeeping gene, GAPDH.
igure 6. Regulatory activity after peptide immunization. Normal L
ither N-CLIP or CLIP-C. Fourteen days later, splenic T cells (1
VHD effector T cells. Spleen cells were stimulated with syngenei
arvested assessed for levels of IL-2 and IFNmRNA transcripts by
or housekeeping gene, GAPDH.
B&MToaded with the CLIP-C peptide. Fourteen days later,
he spleen cells were harvested and assessed for their
bility to suppress the response of the syngeneic
VHD effector T cells. Splenic lymphocytes from
nimals immunized with the CLIP-C peptide inhib-
-C-reactive T-cell subsets. N-CLIP- and CLIP-C-reactive T cells
c GVHD. In addition, CLIP-reactive T-cell subsets were depleted
lls (1  105) were extensively washed and assessed for their ability
 105) stimulated with CLIP presented by syngeneic APCs (1 
L-2 and IFN mRNA transcripts by quantitative PCR. IFN and
regulatory cells and peptide-loaded APCs. Data were standardized
ts were immunized intradermally with syngeneic APCs loaded with
) were harvested and cocultured with equal number of syngeneic
(1  104) loaded with CLIP. After 48 hours of culture, cells were
tative PCR. Data were standardized against mRNA transcript levelsCLIP
ngenei
ds. Ce
cytes (1
els of I
diatedewis ra
 105
c APCs
quanti525
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5ted the in vitro response of the autoreactive lym-
hocytes to stimulation with the autoantigen (MHC
lass II CLIP presented by APCs). Levels of mRNA
ranscripts for both IL-2 and IFN were markedly
educed in the presence of the regulatory cells. There
as a 35  6.3- and a 83  9.4-fold reduction in the
evels of mRNA transcripts for IL-2 and IFN when
he spleen cells from the animals immunized with the
LIP-C peptide were cocultured with the autoreac-
ive effector cells (n  3; P  .05, P  .01, respec-
ively). Interestingly, Foxp3 mRNA transcript expres-
ion in CD4CD25 T cells was increased 30- to
0-fold after immunization with the CLIP-C peptide
hereas stimulation with N-CLIP was ineffective
data not shown).
Subsequent studies further evaluated the speciﬁc-
ty of the response elicited by immunization with the
-CLIP and CLIP-C peptides. As summarized in
igure 7, CD4CD25 T cells from CLIP-C-immu-
ized animals preferentially responded to this peptide
ariant with increased levels of mRNA transcripts for
oth type 2 cytokines (particularly IL-10) and Foxp3.
n the other hand, levels of mRNA transcripts for
ype 1 cytokines were either modestly reduced or
emained unchanged. Comparatively, CD4CD25
igure 7. Response of CD4CD25 T cells after immunization
ith N-CLIP and CLIP-C peptides. Normal Lewis rats were im-
unized intradermally with N-CLIP and CLIP-C peptides pre-
ented by syngeneic APCs. Fourteen days later, CD4CD25
cells (1  105) were stimulated in vitro with syngeneic APCs
1  104) loaded with either N-CLIP or CLIP-C peptide variant.
fter 48 hours of culture, the cells were harvested assessed for
ytokine and Foxp3 mRNA transcript levels by quantitative PCR.
ata were standardized against mRNA transcript levels for house-
eeping gene, GAPDH. These results are representative of 3 sep-nrate experiments.
26cells from N-CLIP-immunized animals preferen-
ially responded to the N-CLIP variant with height-
ned production of mRNA transcripts for type 1 cy-
okines.
Because CD4 T cell–dependent killing is often
aused by the induction of apoptosis, the ex vivo/in
ivo adoptive transfer model was used to examine
as/FasL interaction as a potential mechanism of reg-
lation. In this setting, induction of apoptotic death of
he autoreactive T cells would prevent the adoptive
ransfer of syngeneic GVHD. The results in Table 3
emonstrate that treatment of the primed regulatory
cells with antibody to FasL before coculture pre-
ented the inactivation of the effector T cells and
llowed syngeneic GVHD to be successfully trans-
erred into the secondary recipients. Treatment of the
ffector T lymphocytes with the antibody to FasL was
neffective.
ISCUSSION
During the past several years, a number of studies
ave clearly indicated that CD4CD25 regulatory
cells play a central role in maintaining peripheral
olerance to self-antigens and can facilitate the devel-
pment of transplantation tolerance [17-20,24]. The
ajor subset of CD4 regulatory T cells that occurs
aturally expresses CD25 and is functionally active as
t emigrates from the thymus. In addition, an induc-
ble subset of CD4 regulatory T cells appears to
equire an activation signal before the acquisition of
unctional activity. A breakdown in these regulatory
echanisms often precedes the onset of autoaggres-
ion.
Peripheral regulatory mechanisms are critical in
reventing the development of syngeneic GVHD af-
er autologous or syngeneic BMT [8,10,11]. Charac-
erization of this peripheral regulatory system has pro-
ided some insight into the dynamic nature of the
echanisms that underlie the restoration and mainte-
ance of immune tolerance to self-antigens after BMT
8-11]. The results of the current studies provide ev-
dence that a subset of CD4 T cells can effectively
uppress both the adoptive transfer of syngeneic
VHD and the in vitro cytokine response of the
athogenic autoreactive lymphocytes. This subset of
egulatory T cells may also coexpress CD25. Because
egative depletion techniques were used for the adop-
ive transfer studies, the possibility that effective reg-
lation in vivo requires a subpopulation of CD25
CD8	CD4	) cells that acts synergistically cannot be
xcluded. Of importance, functional regulatory activ-
ty was only detected after the resolution of syngeneic
VHD or after experimental challenge of normal
nimals with the autoreactive T-cell population but
ot in naïve animals. These results suggest that the
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Immune Tolerance to MHC Class Antigens
Bevelopment of functional regulatory activity within
he CD4 T-cell compartment is caused by an active
esponse to the pathogenic autoreactive lymphocytes.
ncounter with the autoreactive T cells leads to
hanges in both the function and phenotype of the
egulatory system. Interestingly, previous studies in
ther animal models of autoimmunity suggest that
egulatory T cells can be primed or activated by chal-
enge with autoreactive lymphocytes [21-24].
Efforts to determine the speciﬁcity of the regula-
ory T cells revealed that these cells through their
lonotypic receptor for antigen recognize the MHC
lass II CLIP complex expressed on the activated
athogenic effector lymphocytes [10]. Because the
athogenic autoreactive T cells also recognize the
HC class II CLIP complex [2-5], the results from
he current study suggest that both the regulatory and
athogenic effector T cells in syngeneic GVHD rec-
gnize a common peptide antigen framework pre-
ented by MHC class II molecules. Surprisingly, these
unctionally distinct subsets of cells can be separated
ased on their differential afﬁnities for variants of CLIP
ontaining either the N- or C-terminal ﬂanking domains
f this peptide [14,25]. Analysis of the CD4CD25
ymphocyte compartment reveals two subpopulations
hat can be deﬁned by antigen speciﬁcity into N-CLIP-
nd CLIP-C-reactive T cells. The CLIP-C-reactive
ubset includes cells that have phenotypic and functional
roperties consistent with regulatory T cells whereas the
-CLIP-reactive cells do not. The CD4CD25
LIP-C-reactive T-cell subset expresses elevated levels
f IL-10 and Foxp3 mRNA transcripts, the nuclear tran-
cription factor preferentially associated with regulatory
cells [15,16,26]. Interestingly, the development of
unctional regulatory activity correlated with in-
reased expression levels of Foxp3 mRNA transcripts
n the CLIP-C-reactive T-cell subset. Comparatively,
he N-CLIP-reactive CD4CD25 T cells did not
ave signiﬁcant regulatory activity and expressed low
evels of Foxp3 mRNA transcripts, suggesting that
D25 expression is not a unique marker for regula-
able 3. Primed CD4 Regulatory T Cells Inactivate Syngeneic GVH
Coculture Before Adoptive Transfer
Effector Population R
yngeneic GVHD effector T cells None
yngeneic GVHD effector T cells Primed
yngeneic GVHD effector T cells  anti-FasL Primed
yngeneic GVHD effector T cells Primed
rimed CD4 regulatory cells (30 106) were irradiated (1250R) an
before the adoptive transfer into secondary Lewis recipients. The
coculture. Treatment of the effector and regulatory T cells with
primed regulatory cells are active in vitro but when transferredory T cells. r
B&MTTemporal analysis of the CLIP-reactive T-cell
ubsets revealed remarkable changes in both the func-
ion and the relative proportion of N-CLIP- and
LIP-C-reactive cells within the CD4CD25
lymphocyte compartment providing unique in-
ights into the maturation of the autoreactive/autoreg-
latory response associated with the development and
esolution of syngeneic GVHD. The CD4CD25
-cell compartment was expanded during active dis-
ase largely because of an increase in the number of
-CLIP T cells with autoreactive effector function.
lthough the relative percentage of CLIP-C-speciﬁc
D4CD25 T cells did not appear to change in
nimals with syngeneic GVHD, there were signiﬁcant
hanges in the functional phenotype of these cells with
ncreased levels of type 1 and 2 cytokine mRNA tran-
cripts compared with CD4CD25 CLIP-C-reac-
ive T cells isolated from naïve animals. These cells
id not have any demonstrable regulatory activity.
he absence of regulatory function in the CLIP-
eactive T-cell subsets harvested during active disease
orrelated with minimal levels of Foxp3 mRNA tran-
cripts. These data are consistent with the expansion
f autoreactive effector T helper cells (that express
D25 on activation). It also appears that the relative
umber of regulatory lymphocytes is decreased in
nimals with syngeneic GVHD. However, it is unclear
hether these cells are functionally active but at a
requency too low to effectively inhibit the autoreac-
ive T cells.
Although regulatory T-cell populations have been
solated from and found to develop in multiple lym-
hoid compartments (lymph node, peripheral blood,
pleen, and bone marrow), the adoptive transfer stud-
es that identiﬁed and characterized the promiscuous
utoregulatory compartment in syngeneic GVHD
sed T cells derived from the spleen. The apparent
ecrease in this regulatory T-cell population in ani-
als with syngeneic GVHD is most likely a result of
delay in the reconstitution of this subset as a result of
sA treatment [5,8,11]. Previous studies indicate that
sA treatment not only inhibits the deletion of auto-
tor Lymphocytes Through a Fas/FasL	 Dependent Mechanism
Incidence of Syngeneic GVHD
in Secondary Recipientsory Population
6/6
tory cells 0/6
tory cells 0/6
tory cells  anti-FasL 5/6
ltured with syngeneic GVHD effector cells (30 106) for 18 hours
tory and effector T cells were treated with antibody to FasL before
al mouse IgG had no effect on their functional activity. Irradiated
ely fail to suppress the adoptive transfer of syngeneic GVHD.D Effec
egulat
regula
regula
regula
d cocu
regula
normeactive T cells but also retards the thymic-dependent
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5evelopment of regulatory lymphocytes [2,11,27]. Re-
onstitution of the CD4 regulatory T-cell compart-
ent only occurs after the discontinuation of CsA
reatment [11,12]. Of interest, recent studies also sug-
est that the regulatory T cells that develop after
essation of CsA treatment are recent thymic emi-
rants because T-cell recombinant excision circles
an be detected in this subset of lymphocytes
11,12]. The failure to reconstitute this subset in
hymectomized hosts also suggests that reconstitu-
ion of the regulatory compartment can occur de
ovo in the thymus [28].
Interestingly, the number of CD4CD25 T cells
nd the relative proportion of CLIP-C-reactive lym-
hocytes within this subset after resolution of synge-
eic GVHD were comparable with the levels detected
n normal animals. However, the CD4CD25T-cell
ubset was now functionally active and capable of
uppressing in vitro responses of the autoreactive
cells whereas depletion of cells expressing either the
D4 or CD25 cell surface marker eliminated in vivo
egulatory activity. CLIP-C-reactive T cells that have
n vitro regulatory function can also be detected
ithin the CD4CD25 subset after resolution of
ctive disease. Acquisition of functional activity was
ot associated with an increase in the relative percent-
ge of reactive T cells but rather correlated with the
p-regulation of IL-10 and Foxp3 mRNA transcripts.
his is somewhat surprising given the relative com-
arability of the total number of antigen-reactive lym-
hocytes within the CD4CD25 CLIP-C-reactive
opulation. The development of regulatory function
ay be a result of either activation of the regulatory
ells or the expansion of a minor population of cells
ithin this compartment. The antigen-reactive regu-
atory T cells may be quiescent unless these cells
eceive an activation signal that promotes the devel-
pment of functional regulatory activity. In many
ystems, activation of regulatory T cells including
D4CD25 lymphocytes by antigen must occur be-
ore the development of functional regulatory activity
17-19,29-31]. The presence of activated autoreactive
cells may also lead to the activation of the regula-
ory T cell as established in several experimental mod-
ls of autoimmunity [21-24]. Alternatively, the results
rom the current study may also be explained by an
xpansion of a minor subpopulation of CD4CD25
oxp3 CLIP-C-reactive T cells within the regula-
ory compartment to sufﬁcient levels that can modify
he activity of the autoreactive lymphocytes. Because
oxp3 is a nuclear transcription factor, enumeration of
D4CD25 Foxp3 CLIP-C-reactive T cells by
ow cytometry would require intracellular staining
nd, therefore, preclude functional assessment of the
ells. Nevertheless, the development of functional ac-
ivity was associated with increased expression of
28oxp3 mRNA transcripts within the CD4CD25
LIP-C-reactive T cells.
Functionally active regulatory cells were also de-
ected after challenge of normal animals with the syn-
eneic GVHD effector T cells or after speciﬁc immu-
ization with the CLIP-C peptide antigen presented
y APCs, the apparent target antigen of the regulatory
cells. It is important to note that both CLIP and
HC class II are presented on the activated autore-
ctive T cells in the rat [3,5]. Challenge with the
utoreactive T cells could represent speciﬁc antigen
hallenge to the regulatory compartment leading to
ctivation and expansion. Because activation of any
cell can in principle lead to expression of the MHC
lass II CLIP complex, CLIP-C-reactive regulatory
cells could be activated. This would effectively set
he stage for local regulation of the immune response.
ndeed, evidence exists that nonconventional CLIP
ragments are presented by MHC class II on dendritic
ells. MHC class II CLIP complexes isolated from
ature dendritic cells were found to contain “short”
LIP peptides that lack the N-terminal domain but
ave the C-terminal ﬂanking region [32]. These acti-
ated APCs are thought to promote skewing of an
utoreactive T-cell response to a type 2 cytokine phe-
otype. Short CLIPs are also differentially expressed
n thymic epithelial cells and thought to play a role in
election of T cells [33]. In settings where the re-
ponses are to very broad and widely distributed an-
igens such as allogeneic BMT, endogenous signaling
f these autoreactive/regulatory T cells would have a
rofound effect. Interestingly, the resolution of acute
llogeneic GVHD in the rat is associated with broadly
peciﬁc regulatory T cells that can dampen the im-
une response to many antigens [7,34-36]. Moreover,
he ﬁnding that a regulatory target antigen can be
xpressed on many T cells after activation implies a
otential mechanism for the generation and mainte-
ance of the CD4 regulatory T-cell compartment.
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